Si prevede che il mercato degli organi su chip crescerà al 30,76% di CAGR dal 2023 al 2030. Si prevede che raggiungerà oltre 262,6 milioni di USD entro il 2030 dai 40,18 milioni di USD nel 2023.
Gli organi artificiali che imitano gli organi umani sono noti come "organi su chip". Si tratta di un apparato di coltura cellulare microfluidico 3D multicanale che stimola le funzioni, i processi e le reazioni fisiologiche degli organi. L'invenzione di un nuovo modello di organismi umani multicellulari in vitro è la conseguenza dell'integrazione di laboratori su chip (LOC) e biologia cellulare, che consente ai ricercatori di studiare la fisiologia umana in un ambiente specifico per organo. Polmoni, intestino, cervello, fegato e cuore sono solo alcuni degli organi in cui questo chip crea un piccolo canale per il passaggio di sangue e aria. Questi dispositivi sono costruiti su un microchip con camere costantemente perfuse riempite di cellule vive e organizzate per stimolare la fisiologia a livello di tessuti e organi. La tecnologia nota come "organo su chip" utilizza il silicone per far crescere gli organi interni.
L'ingegneria tissutale e la microfluidica sono combinate per creare una tecnologia innovativa chiamata organo su chip. Si prevede che queste tecnologie offrano soluzioni efficienti a problemi persistenti nello sviluppo di nuovi farmaci e nel trattamento di alcune malattie. Ha un impatto significativo sugli studi sullo sviluppo di farmaci, il che avvantaggia il mercato dell'organo su chip. La domanda di colture di organi polmonari e applicazioni renali, nonché un aumento della domanda di screening di farmaci, sono ciò che sta guidando il mercato globale degli organi su chip. Si prevede che il mercato dell'organo su chip registrerà una crescita significativa nei prossimi anni a causa dell'aumento delle attività di ricerca che utilizzano dispositivi organo su chip come alternativa ai test sugli animali per la scoperta di nuovi farmaci.
In addition, the healthcare sector's spike in demand for organ-on-chip devices is anticipated to drive growth in the global organ-on-chip market. One use for organ-on-chip technology in the medical field is the real-time imaging, in vitro biochemical analysis, and genetic and metabolic activities of living cells in a functional tissue. Growth in the organ-on-chip market is being fueled by improvements in cell biology, microfabrication, and microfluidics, which have increased the acceptance of organ-on-chips. The demand for lung- and kidney-based organ culture devices as well as an increase in the demand for organ-on-chips in drug screening are anticipated to drive the market for these products. Additionally, it is anticipated that the lack of donor organs and the availability of functional organs created in a lab will be a huge advantage in meeting the expanding need for organ transplantation.
Overall, the market for organs on chips is expected to benefit from the COVID-19 outbreak. In order to increase the hospital capacity for patients diagnosed with COVID-19, a sizable number of clinics and hospitals around the world underwent restructuring. Due to the quick increase of COVID-19 patients, non-essential procedures may have fallen behind. Production and delivery of supplies for healthcare were halted as a result of the lockdown. But during the COVID-19 pandemic, organ-on-chip technology emerged as a viable tool for the creation of medications and vaccines that were being investigated and put through clinical trials for the infection. As a result, during the pandemic, it had a very favorable effect.
ATTRIBUTE | DETAILS |
Study period | 2020-2030 |
Base year | 2022 |
Estimated year | 2023 |
Forecasted year | 2023-2030 |
Historical period | 2019-2021 |
Unit | Value (USD Million) |
Segmentation | By Organ Type, By Application, By End User, By Region |
By Organ Type |
|
By Application |
|
By End User |
|
By Region |
|
The global organs-on-chips market revenue is projected to expand at a CAGR of 30.76% during the forecast period.
The global organs on chips market was valued at USD 40.18 Million in 2023
The organs on chips market key players include TissUse GmbH, Allevi Inc., MIMETAS BV, Netri, BiomimX SRL, Elveflow, Altis Biosystems, Nortis Inc., InSphero, Emulate Inc.
The rise in popularity of organs on chips due to their integration of microfluidics and tissue engineering. These technologies provide efficient solutions to persistent problems in the development of new medications and the treatment of certain diseases. The technique helps in research on drug development. Additionally, the market for organs on chips benefits from rising urbanization, lifestyle modifications, investments, and higher consumer expenditure.
The global organs on chips market is divided into organ type, application, end user, and region.
Due to the availability of a wide range of help provided by important industry pros and an increase in the toxicological examination of medications on the many types of organ cells, North America now holds a monopoly on the organ-on-chip market.
The organs on chips market is segmented based on organ type, application, end user, and region.
[caption id="attachment_30485" align="aligncenter" width="1920"]By organ type the market is segmented into liver, heart, lung, other organ types. A significant portion of the market made up of lung. Lung organ type segments are being created to enhance the physiological relevance of the existing in vitro alveolar-capillary interface models. The alveolar-capillary interface in the human body has specific structural, functional, and mechanical properties that can be accurately mimicked by a multifunctional microdevice of this kind. The market for "lungs on a chip" is anticipated to expand at the fastest CAGR. The need for efficient drug development for respiratory diseases such lung cancer, asthma, and chronic obstructive pulmonary disease (COPD) has led to an increase in the prevalence of these conditions.
[caption id="attachment_30486" align="aligncenter" width="1920"]By application the market is segmented into drug discovery, toxicology research, others. A significant portion of the market made up of drug discovery. Drug testing is primarily utilized for speedy evaluation of samples. To assess the impact of medications on the body, scientists and researchers use organ-on-chip culture systems. With this method, many body organs are also thoroughly tested for drug toxicity or efficacy. The potential of a specific medicine candidate as well as the likelihood of failure can be early identified by researchers using organs-on-chip technology. This component is helping this segment's revenue to increase.
[caption id="attachment_30488" align="aligncenter" width="1920"]By end user the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, other. A significant portion of the market made up of pharmaceutical and biotechnology companies. The market is primarily driven by pharmaceutical and biotechnology companies. This method has great promise for the pharmaceutical and biotech sectors in terms of forecasting adverse effects and the commercial success of medications and biological products. In order to evaluate novel therapies and pharmaceuticals and ensure the safety of novel treatments, where OoC plays a significant role, a complete biological data set may be developed thanks to the increased drug approval failure rates. Many pharmaceutical and biotechnology companies are using this method to hasten the discovery and development of innovative medicines. One of the key factors propelling the market's growth is the increasing use of Organ-on-Chip technology by businesses for medication development.
In 2022, North America had a market share of more than 41%, The rising healthcare applications and cutting-edge technical breakthroughs in the region are mostly to blame for the huge expansion of the North American organs-on-chips market. The region's economic development is further facilitated by the presence of top-tier experts and researchers.
Additionally, the market is growing due to the notable presence of leading suppliers and manufacturers of organs on chips on a global scale. These factors will ultimately increase the demand for organ-on-chip goods in the local market. According to predictions, Asia-Pacific will gain market share. Due to increased disposable income among the public and favorable government funding for regenerative medicine research facilities, the market in the area will expand. Product innovation, cooperative relationships, and private-public strategic alliances will soon increase the market's size.
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.